We are live on
!
Find out more
Keros Therapeutics
KROS
KROS
51 hedge funds and large institutions have $410M invested in Keros Therapeutics in 2020 Q2 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
54.22% more ownership
Funds ownership: 0% → 54.22% (+54%)
Holders
51
Holders Change
+51
Holders Change %
–
% of All Funds
1.05%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.06%
New
51
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$57.8M |
| 2 |
O
OrbiMed
New York
|
+$51.7M |
| 3 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
+$44M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$41.9M |
| 5 |
VA
VR Adviser
New York
|
+$20.7M |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | +$3.08K | +100 | New |
|